Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
Proteome Analysis

Below the proteome analysis is presented. The analysis methods are presented in the paper Propagating Differential Gene Expression in Protein Interaction Networks. If you are interested in the most reliable results choose the
value_type as 'ranked' since this provides a very robust analysis method.
intercation map as 'high confidence'
network_comparison type as 'Divided' since this leads to a natural grouping of similar proteins
filtered as 'true' since this will only use the microarray measurements that have a sufficiently large confidence level.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 1680 to 1729 of 3228 in total
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1680\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CREBL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cyclic-amp-dependent transcription factor atf-6 beta (activating transcription factor 6 beta) (atf6-beta) (camp responsive element binding protein-like 1) (camp response element binding protein-related protein) (creb-rp) (g13 protein). [source:swissprot;acc:q99941]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
216.899\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
213.889\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01407\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1681\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FAM50B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dna segment on chromosome 6(unique) 2654 expressed sequence; dna segment on chromosome x (unique) 2654 expressed sequence. [source:refseq;acc:nm\_012135]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1682\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SRPK2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sfrs protein kinase 2 isoform b. [source:refseq;acc:nm\_182691]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1683\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ATF6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cyclic-amp-dependent transcription factor atf-6 alpha (activating transcription factor 6 alpha) (atf6-alpha). [source:swissprot;acc:p18850]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1684\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SRPK1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sfrs protein kinase 1; sr protein kinase 1. [source:refseq;acc:nm\_003137]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1685\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FAM50A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
xap-5 protein (hxc-26 protein). [source:swissprot;acc:q14320]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1686\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
OSGEPL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
putative sialoglycoprotease type 2. [source:refseq;acc:nm\_022353]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.704\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01399\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1687\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ATP5D\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
atp synthase delta chain, mitochondrial precursor (ec 3.6.3.14). [source:swissprot;acc:p30049]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.345\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.386\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01393\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1688\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MORF4L1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
transcription factor-like protein mrg15 (morf-related gene 15 protein) (mortality factor 4-like 1) (msl3-1 protein) (hspc008/hspc061). [source:swissprot;acc:q9ubu8]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.523\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
231.703\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01392\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1689\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DDX4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dead-box protein 4 (vasa homolog). [source:swissprot;acc:q9nqi0]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.277\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
225.163\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01383\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1690\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RPS24\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
40s ribosomal protein s24 (s19). [source:swissprot;acc:p16632]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.091\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
227.184\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0138\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1691\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EIF5B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
translation initiation factor if-2. [source:swissprot;acc:o60841]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.263\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.315\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01376\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1692\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RBM9\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rna-binding protein 9 (rna binding motif protein 9) (hexaribonucleotide binding protein 2) (repressor of tamoxifen transcriptional activity). [source:swissprot;acc:o43251]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.515\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.551\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01375\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1693\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
IMPDH2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
inosine-5'-monophosphate dehydrogenase 2 (ec 1.1.1.205) (imp dehydrogenase 2) (impdh-ii) (impd 2). [source:swissprot;acc:p12268]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
218.937\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
215.971\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01373\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1694\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GMPS\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gmp synthase [glutamine-hydrolyzing] (ec 6.3.5.2) (glutamine amidotransferase) (gmp synthetase). [source:swissprot;acc:p49915]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1695\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
IMPDH1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
inosine-5'-monophosphate dehydrogenase 1 (ec 1.1.1.205) (imp dehydrogenase 1) (impdh-i) (impd 1). [source:swissprot;acc:p20839]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1696\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PABPC3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
polyadenylate-binding protein 3 (poly(a)-binding protein 3) (pabp 3) (testis-specific poly(a)-binding protein). [source:swissprot;acc:q9h361]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
217.624\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
214.69\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01367\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1697\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KIN\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
hskin17 protein. [source:refseq;acc:nm\_012311]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1698\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CRAT\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
carnitine o-acetyltransferase (ec 2.3.1.7) (carnitine acetylase) (cat). [source:swissprot;acc:p43155]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1699\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PABPC4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
polyadenylate-binding protein 4 (poly(a)-binding protein 4) (pabp 4) (inducible poly(a)-binding protein) (ipabp) (activated-platelet protein-1) (app-1). [source:swissprot;acc:q13310]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1700\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PABPC1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
polyadenylate-binding protein 1 (poly(a)-binding protein 1) (pabp 1). [source:swissprot;acc:p11940]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1701\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
G6PD\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
glucose-6-phosphate 1-dehydrogenase (ec 1.1.1.49) (g6pd). [source:swissprot;acc:p11413]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
216.079\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
219.024\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01363\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1702\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
XRCC3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dna-repair protein xrcc3 (x-ray repair cross-complementing protein 3). [source:swissprot;acc:o43542]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1703\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RECQL5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
atp-dependent dna helicase q5 (recq protein-like 5) (recq5). [source:swissprot;acc:o94762]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1704\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ataxin 2-binding protein. [source:swissprot;acc:q9nwb1]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.514\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.577\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01362\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1705\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PPP4C\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 4 (ec 3.1.3.16) (pp4) (protein phosphatase x) (pp-x). [source:swissprot;acc:p33172]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
223.846\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
220.847\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01358\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1706\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
IGBP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
immunoglobulin-binding protein 1 (cd79a-binding protein 1) (b cell signal transduction molecule alpha 4) (alpha 4 protein). [source:swissprot;acc:p78318]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1707\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BUB1B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mitotic checkpoint serine/threonine-protein kinase bub1 beta (ec 2.7.1.-) (hbubr1) (mad3/bub1-related protein kinase) (mitotic checkpoint kinase mad3l). [source:swissprot;acc:o60566]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
221.283\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
218.334\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01351\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1708\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PNPO\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
pyridoxine 5'-phosphate oxidase. [source:refseq;acc:nm\_018129]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1709\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HHEX\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
homeobox protein prh (hematopoietically expressed homeobox) (homeobox protein hex). [source:swissprot;acc:q03014]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
198.014\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
195.385\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01346\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1710\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
casein kinase i, epsilon isoform (ec 2.7.1.-) (cki-epsilon) (ckie). [source:swissprot;acc:p49674]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
227.225\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.21\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01345\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1711\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HLCS\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
biotin--protein ligase (ec 6.3.4.-) (biotin apo-protein ligase) [includes: biotin--[methylmalonyl-coa-carboxyltransferase] ligase (ec 6.3.4.9); biotin--[propionyl-coa-carboxylase [atp-hydrolyzing]] ligase (ec 6.3.4.10) (holocarboxylase synthetase) (hcs); biotin--[methylcrotonoyl-coa-carboxylase] ligase (ec 6.3.4.11); biotin--[acetyl-coa-carboxylase] ligase (ec 6.3.4.15)]. [source:swissprot;acc:p50747]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.436\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.553\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01337\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1712\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TAF11\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
transcription initiation factor tfiid 28 kda subunit (tafii-28) (tafii28) (tfiid subunit p30-beta). [source:swissprot;acc:q15544]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
208.598\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.375\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01331\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1713\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SH3GL3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sh3-containing grb2-like protein 3 (sh3 domain protein 2c) (een-b2). [source:swissprot;acc:q99963]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.823\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.111\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01329\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1714\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ARMET\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
armet protein precursor (arginine-rich protein). [source:swissprot;acc:p55145]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
206.549\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
203.844\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01327\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1715\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HDC\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
histidine decarboxylase (ec 4.1.1.22) (hdc). [source:swissprot;acc:p19113]\vspace{3pt}}&&&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1716\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SH3GL2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sh3-containing grb2-like protein 2 (sh3 domain protein 2a) (endophilin 1) (een-b1). [source:swissprot;acc:q99962]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.522\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.818\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1717\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
OSGEP\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
o-sialoglycoprotein endopeptidase. [source:refseq;acc:nm\_017807]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.058\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.164\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1718\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SH3GL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sh3-containing grb2-like protein 1 (sh3 domain protein 2b) (extra eleven-nineteen leukemia fusion gene) (een) (een fusion partner of mll). [source:swissprot;acc:q99961]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.251\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.553\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01325\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1719\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
helicase (fragment). [source:sptrembl;acc:q92771]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
187.204\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
189.679\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01322\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1720\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DDX12\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dead/h (asp-glu-ala-asp/his) box polypeptide 11; dead/h box-11 (chl1-related helicase gene-1); yeast chl1 homolog. [source:refseq;acc:nm\_030655]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
187.205\vspace{3pt}}&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1721\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CSNK1D\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
casein kinase i, delta isoform (ec 2.7.1.-) (cki-delta) (ckid). [source:swissprot;acc:p48730]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
227.125\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.164\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01321\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1722\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RPS13\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
40s ribosomal protein s13. [source:swissprot;acc:q02546]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.899\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
223.813\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01319\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1723\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NADK\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
putative inorganic polyphosphate/atp-nad kinase (ec 2.7.1.23) (poly(p)/atp nad kinase). [source:swissprot;acc:o95544]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.147\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01312\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1724\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
IPMK\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
inositol polyphosphate multikinase. [source:refseq;acc:nm\_152230]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
217.676\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
220.53\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01311\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1725\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
AFG3L2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
afg3-like protein 2 (ec 3.4.24.-) (paraplegin-like protein). [source:swissprot;acc:q9y4w6]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1726\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FUT8\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
alpha-(1,6)-fucosyltransferase (ec 2.4.1.68) (glycoprotein 6-alpha-l- fucosyltransferase) (gdp-fucose--glycoprotein fucosyltransferase) (gdp-l-fuc:n-acetyl-beta-d-glucosaminide alpha1,6-fucosyltransferase) (alpha1-6fuct) (fucosyltransferase 8). [source:swissprot;acc:q9byc5]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1727\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
IMPA1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
inositol-1(or 4)-monophosphatase (ec 3.1.3.25) (impase) (imp) (inositol monophosphatase) (lithium-sensitive myo-inositol monophosphatase a1). [source:swissprot;acc:p29218]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.366\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.118\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01308\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1728\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
IMPA2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
inositol-1(or 4)-monophosphatase 2 (ec 3.1.3.25) (impase 2) (imp 2) (inositol monophosphatase 2) (myo-inositol monophosphatase a2). [source:swissprot;acc:o14732]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.358\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.103\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01305\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1729\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ATG12\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
autophagy protein 12-like (apg12-like). [source:swissprot;acc:o94817]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
187.582\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
190.028\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01304\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the HGNC identifier if it exists

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/